Cargando…
The Role of Endocannabinoids System in Fatty Liver Disease and Therapeutic Potentials
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver morbidity and mortality with no proven effective therapy as of yet. Its prevalence is increasing globally in parallel with obesity and metabolic syndrome pandemic. The endocannabinoid (EC) system has been implicated in the pathogene...
Autor principal: | Alswat, Khalid A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745655/ https://www.ncbi.nlm.nih.gov/pubmed/23828743 http://dx.doi.org/10.4103/1319-3767.114505 |
Ejemplares similares
-
History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020) -
Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
por: Bazwinsky-Wutschke, Ivonne, et al.
Publicado: (2019) -
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
por: Tudorancea, Ivona Maria, et al.
Publicado: (2022) -
The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
por: Khayat, Wujood, et al.
Publicado: (2022) -
Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
por: Ambrose, Tim, et al.
Publicado: (2019)